Diabetes drugs are treatments for diabetes by lowering the sugar lower in the blood. Diabetes is a kind of disease with common symptoms such as frequent urination, increased thirst and weight loss. The most common drugs used are insulin and oral medications.
This report aims to provide a comprehensive presentation of the global market for Diabetes Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Drugs. This report contains market size and forecasts of Diabetes Drugs in global, including the following market information:
Global Diabetes Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Diabetes Drugs Market Sales, 2018-2023, 2024-2029, (M Units)
Global top five Diabetes Drugs companies in 2022 (%)
The global Diabetes Drugs market was valued at US$ 55070 million in 2022 and is projected to reach US$ 78860 million by 2029, at a CAGR of 5.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Diabetes Drugs key players include Novo Nordisk, Sanofi, Eli Lilly, Merck & Co, Boehringer Ingelheim, etc. Global top five manufacturers hold a share over 80%.
North America is the largest market, with a share over 50%, followed by Europe and China, both have a share over 30%.
In terms of product, Insulin is the largest segment, with a share over 45%. And in terms of application, the largest application is Type 1 Diabetes, followed by Type 2.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetes Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Diabetes Drugs Market Segment Percentages, by Type, 2022 (%)
- Insulin
- DPP-4
- GLP-1
- SGLT-2
Global Diabetes Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Diabetes Drugs Market Segment Percentages, by Application, 2022 (%)
- Type 1 Diabetes
- Type 2 Diabetes
Global Diabetes Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (M Units)
Global Diabetes Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetes Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Diabetes Drugs revenues share in global market, 2022 (%)
Key companies Diabetes Drugs sales in global market, 2018-2023 (Estimated), (M Units)
Key companies Diabetes Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Sanofi
- AstraZeneca
- Bayer
- Biocon
- Boehringer Ingelheim
- Dongbao Pharmaceutical
- Eli Lilly
- Ganlee
- Ginwa
- Guangzhou Baiyun Mountain
- Hisun Pharmacy
- Hua Dong
- Huadong Medicine
- Jumpcan Pharmacy
- KELUN
- Merck & Co.
- MSD
- North China Pharmaceutical Group Corporation
- Novartis
- Novo Nordisk
- Sanofi
- SHIJIAZHUANG YILING PHARMACEUTICAL
- Takeda
- Taloph
- Tianan Pharmaceutical
- Tonghua DongBao
- Wanbang Biopharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Diabetes Drugs, market overview.
Chapter 2: Global Diabetes Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Diabetes Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Diabetes Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Diabetes Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
Diabetes Drugs Market, Global Outlook and Forecast 2023-2029
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Diabetes Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Diabetes Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Diabetes Drugs Overall Market Size
2.1 Global Diabetes Drugs Market Size: 2022 VS 2029
2.2 Global Diabetes Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Diabetes Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Diabetes Drugs Players in Global Market
3.2 Top Global Diabetes Drugs Companies Ranked by Revenue
3.3 Global Diabetes Drugs Revenue by Companies
3.4 Global Diabetes Drugs Sales by Companies
3.5 Global Diabetes Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Diabetes Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Diabetes Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Diabetes Drugs Players in Global Market
3.8.1 List of Global Tier 1 Diabetes Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Diabetes Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Diabetes Drugs Market Size Markets, 2022 & 2029
4.1.2 Insulin
4.1.3 DPP-4
4.1.4 GLP-1
4.1.5 SGLT-2
4.2 By Type - Global Diabetes Drugs Revenue & Forecasts
4.2.1 By Type - Global Diabetes Drugs Revenue, 2018-2023
4.2.2 By Type - Global Diabetes Drugs Revenue, 2024-2029
4.2.3 By Type - Global Diabetes Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Diabetes Drugs Sales & Forecasts
4.3.1 By Type - Global Diabetes Drugs Sales, 2018-2023
4.3.2 By Type - Global Diabetes Drugs Sales, 2024-2029
4.3.3 By Type - Global Diabetes Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Diabetes Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Diabetes Drugs Market Size, 2022 & 2029
5.1.2 Type 1 Diabetes
5.1.3 Type 2 Diabetes
5.2 By Application - Global Diabetes Drugs Revenue & Forecasts
5.2.1 By Application - Global Diabetes Drugs Revenue, 2018-2023
5.2.2 By Application - Global Diabetes Drugs Revenue, 2024-2029
5.2.3 By Application - Global Diabetes Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Diabetes Drugs Sales & Forecasts
5.3.1 By Application - Global Diabetes Drugs Sales, 2018-2023
5.3.2 By Application - Global Diabetes Drugs Sales, 2024-2029
5.3.3 By Application - Global Diabetes Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Diabetes Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Diabetes Drugs Market Size, 2022 & 2029
6.2 By Region - Global Diabetes Drugs Revenue & Forecasts
6.2.1 By Region - Global Diabetes Drugs Revenue, 2018-2023
6.2.2 By Region - Global Diabetes Drugs Revenue, 2024-2029
6.2.3 By Region - Global Diabetes Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Diabetes Drugs Sales & Forecasts
6.3.1 By Region - Global Diabetes Drugs Sales, 2018-2023
6.3.2 By Region - Global Diabetes Drugs Sales, 2024-2029
6.3.3 By Region - Global Diabetes Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Diabetes Drugs Revenue, 2018-2029
6.4.2 By Country - North America Diabetes Drugs Sales, 2018-2029
6.4.3 US Diabetes Drugs Market Size, 2018-2029
6.4.4 Canada Diabetes Drugs Market Size, 2018-2029
6.4.5 Mexico Diabetes Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Diabetes Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Diabetes Drugs Sales, 2018-2029
6.5.3 Germany Diabetes Drugs Market Size, 2018-2029
6.5.4 France Diabetes Drugs Market Size, 2018-2029
6.5.5 U.K. Diabetes Drugs Market Size, 2018-2029
6.5.6 Italy Diabetes Drugs Market Size, 2018-2029
6.5.7 Russia Diabetes Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Diabetes Drugs Market Size, 2018-2029
6.5.9 Benelux Diabetes Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Diabetes Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Diabetes Drugs Sales, 2018-2029
6.6.3 China Diabetes Drugs Market Size, 2018-2029
6.6.4 Japan Diabetes Drugs Market Size, 2018-2029
6.6.5 South Korea Diabetes Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Diabetes Drugs Market Size, 2018-2029
6.6.7 India Diabetes Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Diabetes Drugs Revenue, 2018-2029
6.7.2 By Country - South America Diabetes Drugs Sales, 2018-2029
6.7.3 Brazil Diabetes Drugs Market Size, 2018-2029
6.7.4 Argentina Diabetes Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Diabetes Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Diabetes Drugs Sales, 2018-2029
6.8.3 Turkey Diabetes Drugs Market Size, 2018-2029
6.8.4 Israel Diabetes Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Diabetes Drugs Market Size, 2018-2029
6.8.6 UAE Diabetes Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Diabetes Drugs Major Product Offerings
7.1.4 Sanofi Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Diabetes Drugs Major Product Offerings
7.2.4 AstraZeneca Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Diabetes Drugs Major Product Offerings
7.3.4 Bayer Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Biocon
7.4.1 Biocon Company Summary
7.4.2 Biocon Business Overview
7.4.3 Biocon Diabetes Drugs Major Product Offerings
7.4.4 Biocon Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Biocon Key News & Latest Developments
7.5 Boehringer Ingelheim
7.5.1 Boehringer Ingelheim Company Summary
7.5.2 Boehringer Ingelheim Business Overview
7.5.3 Boehringer Ingelheim Diabetes Drugs Major Product Offerings
7.5.4 Boehringer Ingelheim Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Boehringer Ingelheim Key News & Latest Developments
7.6 Dongbao Pharmaceutical
7.6.1 Dongbao Pharmaceutical Company Summary
7.6.2 Dongbao Pharmaceutical Business Overview
7.6.3 Dongbao Pharmaceutical Diabetes Drugs Major Product Offerings
7.6.4 Dongbao Pharmaceutical Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Dongbao Pharmaceutical Key News & Latest Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Company Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Diabetes Drugs Major Product Offerings
7.7.4 Eli Lilly Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Eli Lilly Key News & Latest Developments
7.8 Ganlee
7.8.1 Ganlee Company Summary
7.8.2 Ganlee Business Overview
7.8.3 Ganlee Diabetes Drugs Major Product Offerings
7.8.4 Ganlee Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.8.5 Ganlee Key News & Latest Developments
7.9 Ginwa
7.9.1 Ginwa Company Summary
7.9.2 Ginwa Business Overview
7.9.3 Ginwa Diabetes Drugs Major Product Offerings
7.9.4 Ginwa Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.9.5 Ginwa Key News & Latest Developments
7.10 Guangzhou Baiyun Mountain
7.10.1 Guangzhou Baiyun Mountain Company Summary
7.10.2 Guangzhou Baiyun Mountain Business Overview
7.10.3 Guangzhou Baiyun Mountain Diabetes Drugs Major Product Offerings
7.10.4 Guangzhou Baiyun Mountain Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.10.5 Guangzhou Baiyun Mountain Key News & Latest Developments
7.11 Hisun Pharmacy
7.11.1 Hisun Pharmacy Company Summary
7.11.2 Hisun Pharmacy Diabetes Drugs Business Overview
7.11.3 Hisun Pharmacy Diabetes Drugs Major Product Offerings
7.11.4 Hisun Pharmacy Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.11.5 Hisun Pharmacy Key News & Latest Developments
7.12 Hua Dong
7.12.1 Hua Dong Company Summary
7.12.2 Hua Dong Diabetes Drugs Business Overview
7.12.3 Hua Dong Diabetes Drugs Major Product Offerings
7.12.4 Hua Dong Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.12.5 Hua Dong Key News & Latest Developments
7.13 Huadong Medicine
7.13.1 Huadong Medicine Company Summary
7.13.2 Huadong Medicine Diabetes Drugs Business Overview
7.13.3 Huadong Medicine Diabetes Drugs Major Product Offerings
7.13.4 Huadong Medicine Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.13.5 Huadong Medicine Key News & Latest Developments
7.14 Jumpcan Pharmacy
7.14.1 Jumpcan Pharmacy Company Summary
7.14.2 Jumpcan Pharmacy Business Overview
7.14.3 Jumpcan Pharmacy Diabetes Drugs Major Product Offerings
7.14.4 Jumpcan Pharmacy Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.14.5 Jumpcan Pharmacy Key News & Latest Developments
7.15 KELUN
7.15.1 KELUN Company Summary
7.15.2 KELUN Business Overview
7.15.3 KELUN Diabetes Drugs Major Product Offerings
7.15.4 KELUN Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.15.5 KELUN Key News & Latest Developments
7.16 Merck & Co.
7.16.1 Merck & Co. Company Summary
7.16.2 Merck & Co. Business Overview
7.16.3 Merck & Co. Diabetes Drugs Major Product Offerings
7.16.4 Merck & Co. Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.16.5 Merck & Co. Key News & Latest Developments
7.17 MSD
7.17.1 MSD Company Summary
7.17.2 MSD Business Overview
7.17.3 MSD Diabetes Drugs Major Product Offerings
7.17.4 MSD Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.17.5 MSD Key News & Latest Developments
7.18 North China Pharmaceutical Group Corporation
7.18.1 North China Pharmaceutical Group Corporation Company Summary
7.18.2 North China Pharmaceutical Group Corporation Business Overview
7.18.3 North China Pharmaceutical Group Corporation Diabetes Drugs Major Product Offerings
7.18.4 North China Pharmaceutical Group Corporation Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.18.5 North China Pharmaceutical Group Corporation Key News & Latest Developments
7.19 Novartis
7.19.1 Novartis Company Summary
7.19.2 Novartis Business Overview
7.19.3 Novartis Diabetes Drugs Major Product Offerings
7.19.4 Novartis Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.19.5 Novartis Key News & Latest Developments
7.20 Novo Nordisk
7.20.1 Novo Nordisk Company Summary
7.20.2 Novo Nordisk Business Overview
7.20.3 Novo Nordisk Diabetes Drugs Major Product Offerings
7.20.4 Novo Nordisk Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.20.5 Novo Nordisk Key News & Latest Developments
7.21 Sanofi
7.21.1 Sanofi Company Summary
7.21.2 Sanofi Business Overview
7.21.3 Sanofi Diabetes Drugs Major Product Offerings
7.21.4 Sanofi Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.21.5 Sanofi Key News & Latest Developments
7.22 SHIJIAZHUANG YILING PHARMACEUTICAL
7.22.1 SHIJIAZHUANG YILING PHARMACEUTICAL Company Summary
7.22.2 SHIJIAZHUANG YILING PHARMACEUTICAL Business Overview
7.22.3 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Major Product Offerings
7.22.4 SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.22.5 SHIJIAZHUANG YILING PHARMACEUTICAL Key News & Latest Developments
7.23 Takeda
7.23.1 Takeda Company Summary
7.23.2 Takeda Business Overview
7.23.3 Takeda Diabetes Drugs Major Product Offerings
7.23.4 Takeda Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.23.5 Takeda Key News & Latest Developments
7.24 Taloph
7.24.1 Taloph Company Summary
7.24.2 Taloph Business Overview
7.24.3 Taloph Diabetes Drugs Major Product Offerings
7.24.4 Taloph Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.24.5 Taloph Key News & Latest Developments
7.25 Tianan Pharmaceutical
7.25.1 Tianan Pharmaceutical Company Summary
7.25.2 Tianan Pharmaceutical Business Overview
7.25.3 Tianan Pharmaceutical Diabetes Drugs Major Product Offerings
7.25.4 Tianan Pharmaceutical Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.25.5 Tianan Pharmaceutical Key News & Latest Developments
7.26 Tonghua DongBao
7.26.1 Tonghua DongBao Company Summary
7.26.2 Tonghua DongBao Business Overview
7.26.3 Tonghua DongBao Diabetes Drugs Major Product Offerings
7.26.4 Tonghua DongBao Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.26.5 Tonghua DongBao Key News & Latest Developments
7.27 Wanbang Biopharmaceuticals
7.27.1 Wanbang Biopharmaceuticals Company Summary
7.27.2 Wanbang Biopharmaceuticals Business Overview
7.27.3 Wanbang Biopharmaceuticals Diabetes Drugs Major Product Offerings
7.27.4 Wanbang Biopharmaceuticals Diabetes Drugs Sales and Revenue in Global (2018-2023)
7.27.5 Wanbang Biopharmaceuticals Key News & Latest Developments
8 Global Diabetes Drugs Production Capacity, Analysis
8.1 Global Diabetes Drugs Production Capacity, 2018-2029
8.2 Diabetes Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Diabetes Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Diabetes Drugs Supply Chain Analysis
10.1 Diabetes Drugs Industry Value Chain
10.2 Diabetes Drugs Upstream Market
10.3 Diabetes Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Diabetes Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Diabetes Drugs in Global Market
Table 2. Top Diabetes Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Diabetes Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Diabetes Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Diabetes Drugs Sales by Companies, (M Units), 2018-2023
Table 6. Global Diabetes Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Diabetes Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Diabetes Drugs Product Type
Table 9. List of Global Tier 1 Diabetes Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type - Global Diabetes Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Diabetes Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Diabetes Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Diabetes Drugs Sales (M Units), 2018-2023
Table 15. By Type - Global Diabetes Drugs Sales (M Units), 2024-2029
Table 16. By Application - Global Diabetes Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Diabetes Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Diabetes Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Diabetes Drugs Sales (M Units), 2018-2023
Table 20. By Application - Global Diabetes Drugs Sales (M Units), 2024-2029
Table 21. By Region - Global Diabetes Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Diabetes Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Diabetes Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Diabetes Drugs Sales (M Units), 2018-2023
Table 25. By Region - Global Diabetes Drugs Sales (M Units), 2024-2029
Table 26. By Country - North America Diabetes Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Diabetes Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Diabetes Drugs Sales, (M Units), 2018-2023
Table 29. By Country - North America Diabetes Drugs Sales, (M Units), 2024-2029
Table 30. By Country - Europe Diabetes Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Diabetes Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Diabetes Drugs Sales, (M Units), 2018-2023
Table 33. By Country - Europe Diabetes Drugs Sales, (M Units), 2024-2029
Table 34. By Region - Asia Diabetes Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Diabetes Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Diabetes Drugs Sales, (M Units), 2018-2023
Table 37. By Region - Asia Diabetes Drugs Sales, (M Units), 2024-2029
Table 38. By Country - South America Diabetes Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Diabetes Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Diabetes Drugs Sales, (M Units), 2018-2023
Table 41. By Country - South America Diabetes Drugs Sales, (M Units), 2024-2029
Table 42. By Country - Middle East & Africa Diabetes Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Diabetes Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Diabetes Drugs Sales, (M Units), 2018-2023
Table 45. By Country - Middle East & Africa Diabetes Drugs Sales, (M Units), 2024-2029
Table 46. Sanofi Company Summary
Table 47. Sanofi Diabetes Drugs Product Offerings
Table 48. Sanofi Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Diabetes Drugs Product Offerings
Table 52. AstraZeneca Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Diabetes Drugs Product Offerings
Table 56. Bayer Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. Biocon Company Summary
Table 59. Biocon Diabetes Drugs Product Offerings
Table 60. Biocon Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Biocon Key News & Latest Developments
Table 62. Boehringer Ingelheim Company Summary
Table 63. Boehringer Ingelheim Diabetes Drugs Product Offerings
Table 64. Boehringer Ingelheim Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Boehringer Ingelheim Key News & Latest Developments
Table 66. Dongbao Pharmaceutical Company Summary
Table 67. Dongbao Pharmaceutical Diabetes Drugs Product Offerings
Table 68. Dongbao Pharmaceutical Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Dongbao Pharmaceutical Key News & Latest Developments
Table 70. Eli Lilly Company Summary
Table 71. Eli Lilly Diabetes Drugs Product Offerings
Table 72. Eli Lilly Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Eli Lilly Key News & Latest Developments
Table 74. Ganlee Company Summary
Table 75. Ganlee Diabetes Drugs Product Offerings
Table 76. Ganlee Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Ganlee Key News & Latest Developments
Table 78. Ginwa Company Summary
Table 79. Ginwa Diabetes Drugs Product Offerings
Table 80. Ginwa Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. Ginwa Key News & Latest Developments
Table 82. Guangzhou Baiyun Mountain Company Summary
Table 83. Guangzhou Baiyun Mountain Diabetes Drugs Product Offerings
Table 84. Guangzhou Baiyun Mountain Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Guangzhou Baiyun Mountain Key News & Latest Developments
Table 86. Hisun Pharmacy Company Summary
Table 87. Hisun Pharmacy Diabetes Drugs Product Offerings
Table 88. Hisun Pharmacy Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Hisun Pharmacy Key News & Latest Developments
Table 90. Hua Dong Company Summary
Table 91. Hua Dong Diabetes Drugs Product Offerings
Table 92. Hua Dong Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Hua Dong Key News & Latest Developments
Table 94. Huadong Medicine Company Summary
Table 95. Huadong Medicine Diabetes Drugs Product Offerings
Table 96. Huadong Medicine Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. Huadong Medicine Key News & Latest Developments
Table 98. Jumpcan Pharmacy Company Summary
Table 99. Jumpcan Pharmacy Diabetes Drugs Product Offerings
Table 100. Jumpcan Pharmacy Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. Jumpcan Pharmacy Key News & Latest Developments
Table 102. KELUN Company Summary
Table 103. KELUN Diabetes Drugs Product Offerings
Table 104. KELUN Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. KELUN Key News & Latest Developments
Table 106. Merck & Co. Company Summary
Table 107. Merck & Co. Diabetes Drugs Product Offerings
Table 108. Merck & Co. Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Merck & Co. Key News & Latest Developments
Table 110. MSD Company Summary
Table 111. MSD Diabetes Drugs Product Offerings
Table 112. MSD Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. MSD Key News & Latest Developments
Table 114. North China Pharmaceutical Group Corporation Company Summary
Table 115. North China Pharmaceutical Group Corporation Diabetes Drugs Product Offerings
Table 116. North China Pharmaceutical Group Corporation Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. North China Pharmaceutical Group Corporation Key News & Latest Developments
Table 118. Novartis Company Summary
Table 119. Novartis Diabetes Drugs Product Offerings
Table 120. Novartis Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. Novartis Key News & Latest Developments
Table 122. Novo Nordisk Company Summary
Table 123. Novo Nordisk Diabetes Drugs Product Offerings
Table 124. Novo Nordisk Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 125. Novo Nordisk Key News & Latest Developments
Table 126. Sanofi Company Summary
Table 127. Sanofi Diabetes Drugs Product Offerings
Table 128. Sanofi Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 129. Sanofi Key News & Latest Developments
Table 130. SHIJIAZHUANG YILING PHARMACEUTICAL Company Summary
Table 131. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Product Offerings
Table 132. SHIJIAZHUANG YILING PHARMACEUTICAL Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 133. SHIJIAZHUANG YILING PHARMACEUTICAL Key News & Latest Developments
Table 134. Takeda Company Summary
Table 135. Takeda Diabetes Drugs Product Offerings
Table 136. Takeda Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 137. Takeda Key News & Latest Developments
Table 138. Taloph Company Summary
Table 139. Taloph Diabetes Drugs Product Offerings
Table 140. Taloph Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 141. Taloph Key News & Latest Developments
Table 142. Tianan Pharmaceutical Company Summary
Table 143. Tianan Pharmaceutical Diabetes Drugs Product Offerings
Table 144. Tianan Pharmaceutical Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 145. Tianan Pharmaceutical Key News & Latest Developments
Table 146. Tonghua DongBao Company Summary
Table 147. Tonghua DongBao Diabetes Drugs Product Offerings
Table 148. Tonghua DongBao Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 149. Tonghua DongBao Key News & Latest Developments
Table 150. Wanbang Biopharmaceuticals Company Summary
Table 151. Wanbang Biopharmaceuticals Diabetes Drugs Product Offerings
Table 152. Wanbang Biopharmaceuticals Diabetes Drugs Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 153. Wanbang Biopharmaceuticals Key News & Latest Developments
Table 154. Diabetes Drugs Production Capacity (M Units) of Key Manufacturers in Global Market, 2021-2023 (M Units)
Table 155. Global Diabetes Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 156. Global Diabetes Drugs Production by Region, 2018-2023 (M Units)
Table 157. Global Diabetes Drugs Production by Region, 2024-2029 (M Units)
Table 158. Diabetes Drugs Market Opportunities & Trends in Global Market
Table 159. Diabetes Drugs Market Drivers in Global Market
Table 160. Diabetes Drugs Market Restraints in Global Market
Table 161. Diabetes Drugs Raw Materials
Table 162. Diabetes Drugs Raw Materials Suppliers in Global Market
Table 163. Typical Diabetes Drugs Downstream
Table 164. Diabetes Drugs Downstream Clients in Global Market
Table 165. Diabetes Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Diabetes Drugs Segment by Type in 2022
Figure 2. Diabetes Drugs Segment by Application in 2022
Figure 3. Global Diabetes Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Diabetes Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Diabetes Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Diabetes Drugs Sales in Global Market: 2018-2029 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Diabetes Drugs Revenue in 2022
Figure 9. By Type - Global Diabetes Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Diabetes Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Diabetes Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Diabetes Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Diabetes Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Diabetes Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Diabetes Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Diabetes Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Diabetes Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Diabetes Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Diabetes Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Diabetes Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Diabetes Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Diabetes Drugs Sales Market Share, 2018-2029
Figure 23. US Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Diabetes Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Diabetes Drugs Sales Market Share, 2018-2029
Figure 28. Germany Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Diabetes Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Diabetes Drugs Sales Market Share, 2018-2029
Figure 37. China Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Diabetes Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Diabetes Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Diabetes Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Diabetes Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Diabetes Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Diabetes Drugs Production Capacity (M Units), 2018-2029
Figure 53. The Percentage of Production Diabetes Drugs by Region, 2022 VS 2029
Figure 54. Diabetes Drugs Industry Value Chain
Figure 55. Marketing Channels
Global Metformin Hydrochloride Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 104
Metformin hydrochloride is The raw material of finished product metformin hydrochloride drugs. That is The API metformin hydrochloride. Metformin Hydrochloride finished product is an oral antihyperglycemic drug used in The management of type 2-diabetes. Metformin hydrochloride (N, N-dimethylimidodicarbonimidic diamide hydrochloride) is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents.
Metformin hydrochloride is a white to off-white crystall......
Global Antidiabetic Sulphonylureas Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 04-Jan-2024 Price: US 3380 Onwards Pages: 112
Market Overview of Global Antidiabetic Sulphonylureas market:
According to our latest research, the global Antidiabetic Sulphonylureas market looks promising in the next 5 years. As of 2022, the global Antidiabetic Sulphonylureas market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of t......
Global Insulin Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 101
According to our LPI (LP Information) latest study, the global Insulin market size was valued at US$ million in 2023. With growing demand in downstream market, the Insulin is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Insulin market. Insulin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization......
Global Insulin API Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 116
According to our LPI (LP Information) latest study, the global Insulin API market size was valued at US$ 1707.6 million in 2023. With growing demand in downstream market, the Insulin API is forecast to a readjusted size of US$ 2101.4 million by 2030 with a CAGR of 3.0% during review period.
The research report highlights the growth potential of the global Insulin API market. Insulin API are expected to show stable growth in the future market. However, product differentiation, reducing co......
Global Glucagon Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 101
According to our LPI (LP Information) latest study, the global Glucagon market size was valued at US$ 543.9 million in 2023. With growing demand in downstream market, the Glucagon is forecast to a readjusted size of US$ 835.7 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Glucagon market. Glucagon are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Acarbose Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 95
According to our LPI (LP Information) latest study, the global Acarbose market size was valued at US$ 135.8 million in 2023. With growing demand in downstream market, the Acarbose is forecast to a readjusted size of US$ 165.9 million by 2030 with a CAGR of 2.9% during review period.
The research report highlights the growth potential of the global Acarbose market. Acarbose are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
Global Insulin Glargine Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 77
According to our LPI (LP Information) latest study, the global Insulin Glargine market size was valued at US$ 6562.1 million in 2023. With growing demand in downstream market, the Insulin Glargine is forecast to a readjusted size of US$ 8722.5 million by 2030 with a CAGR of 4.1% during review period.
The research report highlights the growth potential of the global Insulin Glargine market. Insulin Glargine are expected to show stable growth in the future market. However, product differen......
Global Liraglutide Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 103
According to our LPI (LP Information) latest study, the global Liraglutide market size was valued at US$ million in 2023. With growing demand in downstream market, the Liraglutide is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Liraglutide market. Liraglutide are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply ch......
Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 96
According to our LPI (LP Information) latest study, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was valued at US$ 8624.4 million in 2023. With growing demand in downstream market, the Glucagon Like Peptide-1 (GLP-1) Agonists is forecast to a readjusted size of US$ 21310 million by 2030 with a CAGR of 13.8% during review period.
The research report highlights the growth potential of the global Glucagon Like Peptide-1 (GLP-1) Agonists market. Glucagon Like Peptide-1 (GL......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
